Inventor
BACAC MARINA
CH25 patents
⚠️ This page may combine multiple inventors who share the name “BACAC MARINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
11 patentsUS9914776B2Mar 13, 2018
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE16 citations92
US10611840B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10611841B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US11718680B2Aug 8, 2023
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists
HOFFMANN LA ROCHE5 citations73
US11117965B2Sep 14, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE2 citations73
US10596257B2Mar 24, 2020
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies
HOFFMANN LA ROCHE5 citations68
US12139553B2Nov 12, 2024
T cell activating bispecific antigen binding molecules
HOFFMANN LA ROCHE0 citations62
US10766967B2Sep 8, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations62
US10882918B2Jan 5, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations57
US11013801B2May 25, 2021
Treatment method
HOFFMANN LA ROCHE1 citations56
US12565530B2Mar 3, 2026
Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody
HOFFMANN LA ROCHE0 citations50
ROCHE GLYCART AG
8 patentsUS10577429B2Mar 3, 2020
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG17 citations94
US10253110B2Apr 9, 2019
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG15 citations94
US11332545B2May 17, 2022
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG6 citations86
US10155815B2Dec 18, 2018
Bispecific T cell activating antigen binding molecules
ROCHE GLYCART AG12 citations83
US11459404B2Oct 4, 2022
Bispecific T cell activating antigen binding molecules
ROCHE GLYCART AG5 citations72
US10781258B2Sep 22, 2020
Bispecific T cell activating antigen binding molecules
ROCHE GLYCART AG4 citations72
US12286486B2Apr 29, 2025
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG0 citations62
US10781257B2Sep 22, 2020
Bispecific T cell activating antigen binding molecules
ROCHE GLYCART AG1 citations62